SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
Conclusion & alert: CVE-2007-6763 is rated Moderate Risk (57/100): CVSS High severity, with medium exploitation likelihood (EPSS 0.51%).Mandatory action: Review affected assets and schedule remediation.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
Exploit prediction scoring system (EPSS) score for CVE-2007-6763
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).